Position in IMCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,038,637
New position
Shares Held
100,784
first reported quarter
Ownership
0.198%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 62.459318939514205.ToString("F0")%
Shared 0.ToString("F0")%
None 37.540681060485795.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026LORD, ABBETT & CO. LLC holds $1,298,705,726 across 29 Biotechnology names. IMCR ranks #28 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,812,938 | $148,298,091 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
242,726 | $127,059,779 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,181,270 | $122,447,082 | |
| 4 | ARGX |
Argenx SE
|
152,083 | $111,058,610 | |
| 5 | ABVX |
Abivax S.A.
|
854,920 | $95,195,342 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
1,023,341 | $75,993,302 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,509 | $74,352,928 | |
| 8 | INSM |
INSMED Inc
|
397,261 | $64,960,118 |
All Filings in IMCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,038,637 | 100,784 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||